+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Myocardial Infarction Drug"

Myocardial Infarction Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Myocardial Infarction Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 95 Pages
  • Global
From
Dalteparin Sodium Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Dalteparin Sodium Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • January 2024
  • 111 Pages
  • Global
From
Myocardial Infarction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Myocardial Infarction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • May 2022
  • 270 Pages
  • Global
From
Loading Indicator

The Myocardial Infarction Drug market is a subset of the Cardiovascular Drugs market, which includes drugs used to treat and prevent heart diseases. Myocardial Infarction Drugs are used to treat acute myocardial infarction (AMI), also known as a heart attack. These drugs are used to reduce the risk of death and complications from AMI, such as heart failure, arrhythmias, and stroke. Commonly used Myocardial Infarction Drugs include anticoagulants, antiplatelet agents, beta-blockers, and statins. These drugs are used to reduce the risk of blood clots, reduce inflammation, and lower cholesterol levels. Some companies in the Myocardial Infarction Drug market include Pfizer, Merck, Sanofi, AstraZeneca, and Bristol-Myers Squibb. Show Less Read more